Dr. William Richard Silveira, MD

Dr. Silveira practices at Clovis Community Medical Center in Clovis, California, part of Community Health System.

Dr. Silveira's NPI, 1447494398, was assigned on April 22, 2009. Dr. Silveira graduated from Harvard Medical School in 2009. Dr. Silveira holds California license A115447.

Dr. Silveira's primary practice is Clovis Community Medical Center, at 2755 Herndon Ave, Clovis, CA 93611 in Fresno County. The practice phone is (559) 324-4000.

Dr. Silveira's primary practice is Clovis Community Medical Center in Clovis, California, part of Community Health System. Dr. Silveira is also affiliated with Community Regional Medical Center. The medical group on file is Community Health Partners. Dmand AI also links Dr. Silveira to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silveira practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Silveira's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Silveira is board certified in radiation oncology by the American Board of Radiology. Dr. Silveira is licensed in California.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Silveira treats.

CMS data shows 3,278 Medicare services from Dr. Silveira across 20 procedure codes in 2024, for 312 Medicare patients. Medicare paid $220,595 for them.

CMS counts 312 Medicare patients who saw Dr. Silveira in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have cancer, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silveira's median patient age at 69, with 55% women.

In 2024, Dr. Silveira wrote 86 Medicare Part D claims for 42 patients. 90% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $374 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Silveira for performance year 2024, reported as part of a group. Dr. Silveira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silveira as offering telehealth.

Dmand AI links 7 papers to Dr. Silveira, published from 2015 to 2019. The most frequent topics are Radiation Oncology and Tobacco Use Cessation. Dr. Silveira's most frequent co-authors are Steve Braunstein, MD, PhD, Shannon Elizabeth Fogh, MD and Alina Uzelac, DO.

Dmand AI links Dr. Silveira to 2 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Lung Neoplasms, Pancreatic Intraductal Neoplasms and Neoplasms, Ductal, Lobular, and Medullary.

CMS Open Payments shows 11 general payments to Dr. Silveira from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Varian Medical Systems, Inc. paid the most, $111.

Dr. Silveira graduated from Harvard Medical School in 2009. Dr. Silveira is a member of AMA and ASTRO.

Dr. Silveira is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.